Intelligent Bio Solutions Inc.INBS
Price (close)
$1.71
Market cap
$5.2M
P/E
—
Revenue (TTM)
$4.2M
Net income
-$12.4M
Dividend yield
—
1-year total return
-86.6%
Net margin
-294.9%
Revenue growth
20.9%
Debt / equity
—
What Intelligent Bio Solutions Inc. does.
5, 2016, under the laws of the state of Delaware. The Company’s Australian subsidiary, Intelligent Bio Solutions (APAC) Pty Ltd, was formed on August 4, 2016, under the laws of New South Wales,
Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and
screening solutions. The Company operates globally with the objective of providing innovative and accessible solutions that improve the
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $2.0M | $437,146 | $1.3M | $3.1M | $3.1M | $4.2M |
| Net income | -$7.0M | -$8.3M | -$10.6M | -$10.2M | -$10.6M | -$12.4M |
| Free cash flow | — | — | — | -$9.8M | -$9.9M | -$12.1M |
More on INBS.
- Intelligent Bio Solutions Inc. summary
- Intelligent Bio Solutions Inc. financial statements
- Intelligent Bio Solutions Inc. key metrics
- Intelligent Bio Solutions Inc. health scores and style box
- Intelligent Bio Solutions Inc. earnings
- Intelligent Bio Solutions Inc. dividends
- Intelligent Bio Solutions Inc. valuation
- Intelligent Bio Solutions Inc. ownership and insiders
- Intelligent Bio Solutions Inc. peers
Figures from Intelligent Bio Solutions Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.